Is visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?

Cardiovascular Diabetology
Ryotaro BouchiYoshihiro Ogawa

Abstract

We aimed to investigate whether visceral adiposity could modify the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes. This cross-sectional study examines the interaction of visceral adiposity with increased blood pressure on arterial stiffness and albuminuria. 638 patients with type 2 diabetes (mean age 64 ± 12 years; 40 % female) were enrolled. Visceral fat area (VFA, cm(2)) was assessed by a dual-impedance analyzer, whereby patients were divided into those with VFA < 100 (N = 341) and those with VFA ≥ 100 (N = 297). Albuminuria was measured in a single 24-h urine collection (UAE, mg/day) and brachial-ankle pulse wave velocity (ba-PWV, cm/s) was used for the assessment of arterial stiffening. Linear regression analyses were used to investigate the association of systolic blood pressure (SBP) and VFA with UAE and baPWV. Patients with VFA ≥ 100 were significantly younger, had higher SBP, HbA1c, triglycerides, UAE, alanine aminotransferase, C-reactive protein and lower high-density lipoprotein and shorter duration of diabetes than those with VFA < 100. SBP was significantly and almost equivalently associated with ba-PWV both in VFA < 100 (standardized β 0.224, p = 0.001) and VFA ≥ 10...Continue Reading

References

Dec 24, 1997·Diabetes Care·P J AndersonJ A Critchley
Aug 31, 1999·Journal of Hypertension·M S RumantirM D Esler
Oct 8, 1999·The New England Journal of Medicine·E Ritz, S R Orth
Jan 12, 2001·Journal of the American College of Cardiology·M A WeberD H Smith
Jul 24, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Akira YamashinaYoshio Yamamoto
Apr 23, 2003·Hypertension·Masahiko TozawaShuichi Takishita
Apr 8, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Kevin P Davy, John E Hall
Jun 16, 2004·Annals of Internal Medicine·Tomoshige HayashiWilfred Y Fujimoto
Jun 7, 2005·Journal of the American Society of Nephrology : JASN·Francesco P Schena, Loreto Gesualdo
Apr 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Seiichi MatsuoUNKNOWN Collaborators developing the Japanese equation for estimated GFR
Oct 1, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ryotaro BouchiYasuhiko Iwamoto
Aug 20, 2011·Clinical Journal of the American Society of Nephrology : CJASN·George ThomasSankar D Navaneethan
Jan 10, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Kelly PutnamLisa A Cassis
Apr 19, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Atsuhiro KannoYutaka Imai
Jun 29, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Akira FujiyoshiUNKNOWN Observational Cohorts in Japan (EPOCH-JAPAN) Research Group
Jan 17, 2013·Journal of the American Society of Hypertension : JASH·Steven G Chrysant, George S Chrysant
Jul 5, 2013·Journal of Hypertension·Abdellah Salah MansourJacques Blacher
Jul 16, 2013·Journal of the American College of Cardiology·Kathryn A BrittonCaroline S Fox
Apr 16, 2014·Nature Reviews. Endocrinology·Vincent G DeMarcoJames R Sowers
May 3, 2014·Kidney International·Mark E MolitchCarl E Mogensen
Oct 19, 2010·Journal of Diabetes Investigation·Yutaka SeinoKohjiro Ueki
Sep 6, 2014·Journal of the American College of Cardiology·Alvin ChandraAslan T Turer
Mar 15, 2015·Circulation Research·John E HallMichael E Hall
Dec 17, 2015·Journal of Nutrigenetics and Nutrigenomics·Katie GoodwinZdenka Pausova

❮ Previous
Next ❯

Methods Mentioned

BETA
urine collection

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.